Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059513 · ClinicalTrials.gov registry record
Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 167
- Enrollment target
NCT01059513 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 167 participants.
The verdict
NCT01059513 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
Study Summary
This is an observational study in which a questionnaire is used to obtain quality of life data after patients undergo a hypo-fractionated course of stereotactic body radiotherapy (SBRT) for the treatment of their prostate cancer. The SBRT itself is considered standard of care for these patients and as such, is not an official component of the study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2010-01-26 |
| Est. Completion | 2020-03-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01059513
The ClinicalTrials.gov registry entry for NCT01059513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01059513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01059513 about?
NCT01059513 is a clinical study titled "Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer". This is an observational study in which a questionnaire is used to obtain quality of life data after patients undergo a hypo-fractionated course of stereotactic body radiotherapy (SBRT) for the treatment of their prostate cancer. The SBRT itself is considered standard of care for these patients and ...
What is the current status of trial NCT01059513?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2010-01-26. Estimated completion is 2020-03-19.
Who is sponsoring clinical trial NCT01059513?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.